Simplex Trading »

Contineum Therapeutics shares owned by Simplex Trading

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Simplex Trading from 13F filings

Historical chart of Simplex Trading investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Simplex Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Simplex Trading

Quarter filed Position value Share count Share price at filing
2025-09-30 $10k 895 11.17

More positions owned by Simplex Trading

Spdr S&p 500 Etf Tr Put Put Option
Spdr S&p 500 Etf Tr Call Call Option
Invesco Qqq Tr Put Put Option
Tesla Put Put Option
Nvidia Corporation Put Put Option
Tesla Call Call Option
Invesco Qqq Tr Call Call Option
Nvidia Corporation Call Call Option
Ishares Tr Put Put Option
Ishares Tr Call Call Option
Spdr Gold Tr Call Call Option
Apple Put Put Option
Alphabet Call Call Option
Apple Call Call Option
Meta Platforms Call Call Option

View all positions for Simplex Trading

Top funds holding Contineum Therapeutics

RA Capital Management
Johnson & Johnson
Suvretta Capital Management
Franklin Resources
Vanguard Group
Balyasny Asset Management
FMR
Sectoral Asset Management
Perceptive Advisors
Hillhouse Capital Advisors
Millennium Management
Red Tree Management
Samsara BioCapital
Versant Venture Management
Point72 Asset Management

View all funds holding Contineum Therapeutics